Daniel M. Schmitt - Aug 14, 2024 Form 4 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)

Role
President, CEO and Director, Director
Signature
/s/ Paul Lytle, Attorney-in-Fact
Stock symbol
ACTU
Transactions as of
Aug 14, 2024
Transactions value $
$0
Form type
4
Date filed
8/14/2024, 07:29 PM
Previous filing
Aug 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACTU Restricted Stock Units Award $0 +544K $0.00* 0 Aug 14, 2024 Common Stock 544K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 544,111 restricted stock units granted upon the closing of the issuer's initial public offering on August 14, 2024, 50% of which vest on the first anniversary of the closing of such transaction and 50% of which vest on the second anniversary of the closing of such transaction.